Internal Quality Control in the Haemostasis laboratory. Dr Steve Kitchen Sheffield Haemophilia and Thrombosis centre & UK NEQAS Blood Coagulation
|
|
- Darren Henderson
- 5 years ago
- Views:
Transcription
1 Internal Quality Control in the Haemostasis laboratory Dr Steve Kitchen Sheffield Haemophilia and Thrombosis centre & UK NEQAS Blood Coagulation
2 Disclosures None
3 What is Quality Control? In a medical laboratory situation :- All the processes used to ensure results are safe to release for clinical management - valid and accurate
4
5 Why do we need Quality control? Philadelphia Enquirer Aug Lab used an insensitive chemical for 7 weeks believing it to be sensitive. Patient questioned escalating coumadin dose Patient with INR bleeding from gums INR result at another site 5.7 PTs performed with ISI.8 INRs calculated with ISI.0 Amongst 932 patients - 5 deaths linked
6 Quality Assurance measures taken to ensure the reliability of laboratory sampling, testing and reporting IQC ensures precision and consistency of results for reporting EQA retrospective analysis comparing results between laboratories and between methods UK NEQAS Coagulation
7 Inaccurate and imprecise This assay is inaccurate and imprecise
8 Inaccurate but precise This assay is inaccurate but precise
9 Accurate and imprecise This assay is accurate but imprecise
10 Accurate and precise The assay producing the results shown is both accurate and precise
11 Quality control materials
12 Quality Control Material A substance used in routine practice for checking the concurrent performance of an analytical process It must be similar in properties to and be analysed along with the patient specimens ICSH 984
13 IQC materials All vials or aliquots identical Stable over period of use (lyophilised,frozen)
14
15 Frequency of testing Screening tests CLSI - PT and APTT (Marlar et al 2008) At least 2 levels every 8 hours. After any reagent change. After daily maintenance. At least level every 4 hours if continuous processing.
16 IQC What level? Screening tests CLSI - PT and APTT (Marlar et al 2008) One level in normal/reference range One abnormal in clinically relevant range.
17 IQC What level? Specialist testing -batch analysis Large batches (thrombophilia etc) Two levels as for screening tests Small batches (factor assays) CLSI recommends 2 levels WFH level (preferably at the interface of normal/abnormal)
18 D e Date of Test FVIII (iu/ml) Internal Quality Control results for FVIII:C Assay Target range is mean ± 2sd of 20 determinations
19 Out of range results Single rule Single result exceeds a particular threshold triggers action. Statistically inevitable from time to time without analytical problem Multiple rules eg Westgard rules with defined criteria from multiple IQC levels/tests reduces false rejections
20 Single rule IQC out of target range? Suspend new patient testing and reporting of results since last QC result within limits. Re-test to exclude analytical error. Still out?
21 Single rule IQC out of target range? Suspend new patient testing and reporting of results since last QC result within limits. Re-test to exclude analytical error. Still out? Replace QC material and retest. Still out?
22 Single rule IQC out of target range? Suspend new patient testing and reporting of results since last QC result within limits. Re-test to exclude analytical error. Still out? Replace QC material and retest. Still out? Replace reagents and retest. Still out?
23 Single rule IQC out of target range? Suspend new patient testing and reporting of results since last QC result within limits. Re-test to exclude analytical error. Still out? Replace QC material and retest. Still out? Replace reagents and retest. Still out? Suspend method and switch to backup, and contact higher authority Maintain an error log of these interventions
24 Troubleshooting IQC Why 2 levels? PT PT 2 APTT APTT 2 problem out in out in QC material In Out In out QC 2 material out out in in PT reagent In In Out Out APTT reagent Out Out Out Out Instrument or common reagent
25 Shift following change in lot number of reagent (test strip) INR TARGET VALUES Range POC INR with excessively wide target range and showing a shift
26 IQC _APTT results showing a trend APTT (sec) Trend to higher results as a gradual change in Material, reagent or analyser
27 IQC chart APTT- Unstable IQC sample New vial of IQC 5 0 APTT (sec)
28 Stability of APTT on 2 lyophilised plasmas after reconstituion APTT (sec) Time in Min after reconstitution ph 8.6 and 8.9 indicates in adequate buffering
29 Stability of Frozen samples for FVIII assay ( stage) (Woodhams et al 200) Frozen/stored 74 o C Frozen -74 o C Stored 24 o C Frozen/Stor ed 24 o C < 5% change < 0% change 6 months 3 months 3 months 8 months 6 months 3 months
30 Internal Quality Control Point of Care INR testing
31 OBoard QC Built into test strips Currently -CUC XS and CUC XS Plus -Protime -INRatio Useful for strip integrity Not all show result and/or range Useful but not sufficient alone as IQC.
32 Electronic QC
33 Electronic QC Material Sends electrical pulse to the device Checks internal circuits are working properly Range -Level INR seconds -Level 2 INR seconds Useful but not sufficient alone as IQC.
34 POC INR Wet testing is needed? When starting a new batch of test strips Any unexpected high or low results At least one per clinic (depending on clinic size)
35 POC INR - IQC information to record Date of test Batch of IQC used Range for IQC batch Batch of test strips used Operator ID
36
37 How could St Agnes miss the problem? Level IQC with target range INR Test result of 2.5 sec determined with ISI.8 should have been INR.0 (in range) Calculation done using ISI of.0 INR of.2 (in range) Problem not detected
38 How could St Agnes miss the problem? Inclusion of an abnormal IQC would have detected the error Level 2 IQC target range INR Consider IQC result of 20 sec ISI of.8 (used for analysis) = INR of 2.9 ISI of.0 (used for calculation) = INR of.8 ie Out of range suspend reporting
39 IQC for Coagulation Tests Summary QC material with similar properties to test samples More than level with adequate testing frequency Display target values Maintain a cumulative record Keep a written procedure for intervention with record of actions taken Vigilant, motivated, well informed staff!
Internal Quality Control in the Haemostasis laboratory. Dr Steve Kitchen Sheffield Haemophilia and Thrombosis centre & UK NEQAS Blood Coagulation
Internal Quality Control in the Haemostasis laboratory Dr Steve Kitchen Sheffield Haemophilia and Thrombosis centre & UK NEQAS Blood Coagulation Why do we need Quality control? Philadelphia Enquirer Aug
More informationPoint of Care Testing in Coagulation
Point of Care Testing in Coagulation Dr Steve Kitchen Scientific Director,UK NEQAS Blood Coagulation Head Scientist Coagulation Laboratory, Royal Hallamshire Hospital Sheffield UK POCT in Haemostasis Patient
More informationLOGO. Department of Clinical Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University & Thai Society of Clinical Pathology
LOGO Improvement of Coagulation Lab Practice in Thailand via Thailand NEQAS for Blood Coagulation : 4-year Experience Nisarat Opartkiattikul MD,PhD Panutsaya Tientadakul, MD. Department of Clinical Pathology,
More informationThe challenges of quality assessment for point-of-care testing. Anne Stavelin. EQALM Symposium, Bergen 8 October General challenges
The challenges of quality assessment for point-of-care testing Anne Stavelin EQALM Symposium, Bergen 8 October 2015 www.noklus.no Norwegian quality improvement of primary care laboratories General challenges
More informationHemostasis Test Validation, Performance and Reference Intervals
Hemostasis Test Validation, Performance and Reference Intervals Richard A. Marlar, Ph.D. Pathology and Laboratory Medicine Oklahoma City VA Medical Center University of Oklahoma Health Sciences Center
More informationFarouk AL Quadan lecture 3 Implentation of
How to implement a program? Establish written policies and procedures Assign responsibility for monitoring and reviewing Train staff Obtain control materials Collect data Set target values (mean, SD) Establish
More informationPoint of Care Testing for INR using CoaguChek XS Plus
Point of Care Testing, Pathology Page 1 of 18 Point of Care Testing for INR using CoaguChek XS Plus EDITION No 1.4 DATE OF ISSUE Feb 2014 REVIEW INTERVAL AUTHOR LOCATION OF COPIES 3 YEARS D O Neill 1.
More informationFactor VIII Inhibitor Testing: Nijmegen Modifications, Experience and Recommendations
Factor VIII Inhibitor Testing: Nijmegen Modifications, Experience and Recommendations Bert Verbruggen Radboud University Nijmegen Medical Centre The Netherlands 2-12-2008 DISCLOSURE None 2-12-2008 2 ECAT
More informationHow Good is your INR? The Use of Certified Plasmas in PT/INR Testing. INR System. How Good is your INR? Outline
How Good is your INR? The Use of Certified Plasmas in PT/INR Testing Dot Adcock, MD Esoterix Coagulation Mayo/NASCOLA Coagulation Testing Quality Conference April 25, 2007 How Good is your INR? The Use
More informationINTERNAL QUALITY CONTROL ( Q I C) QC)
EXTERNAL QUALITY ASSESSMENT PROGRAM (EQAP) BIOCHEMISTRY DEPARTMENT R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty TWO COMPLEMENTARY COMPONENETS OF TQM ARE Internal Quality Control (IQC)
More informationBehzad Poopak, DCLS PhD
Behzad Poopak, DCLS PhD Test Report Name Age Critical Low HEMATOLOGY Activated Partial Thromboplastin Time, Plasma Critical High - 150 sec Units Fibrinogen 60 - mg/dl INR (International Normalizing
More informationNew Anticoagulants: Laboratory Monitoring?? Dr Steve Kitchen Sheffield Haemostasis and Thrombosis centre UK
New Anticoagulants: Laboratory Monitoring?? Dr Steve Kitchen Sheffield Haemostasis and Thrombosis centre UK Ideal Anticoagulant (Hirsh et al 2004) High efficacy to safety ratio Predictable dose response
More informationP re-analytical conditions are very important in laboratory assessment of hemostatic and coagulation systems
OPEN SUBJECT AREAS: PRE-CLINICAL STUDIES PROTEASES BIOCHEMICAL ASSAYS BIOPHYSICAL CHEMISTRY Received 19 November 2013 Accepted 8 January 2014 Published 27 January 2014 Correspondence and requests for materials
More informationControl of Foot-and-Mouth Disease
Control of Foot-and-Mouth Disease Detect and confirm outbreaks Investigate outbreaks (source, spread, serotype..) Estimate incidence of the disease Estimate vaccination coverage and efficiency Surveillance
More informationUse of PSI on CS instruments
Johan Claes, Version 01, 1 st September 2016 User day hemostasis 2016 Use of PSI on CS instruments Restricted Siemens Healthcare GmbH, 2016 Hemostasis Lab Challenges Preanalytical problems in Haemostasis
More informationRoche CoaguChek XS Plus INR
Page 1 of 8 Roche CoaguChek XS Plus INR Edition No: 6.0 Author: Paul Simpson Operative Date: October 2016 Review Date: October 2017 Location: Country Health SA Integrated Cardiovascular Clinical Network
More informationDisclosures. Point of Care Testing (POCT) for Anticoagulation Monitoring. Point of Care Anticoagulation Monitoring. Questions.
Point of Care Testing (POCT) for Anticoagulation Monitoring Paula J. Santrach MD Consultant, Division of Transfusion Medicine Associate Professor, Laboratory Medicine Mayo Clinic Rochester, M Disclosures
More informationEvaluation Report. Eurolyser PT (INR) test kit (ST0180) on CUBE and smart analysers
Evaluation Report Eurolyser PT test kit (ST0180) on CUBE and smart analysers Locations Location 1: Eurolyser Diagnostica GmbH Operator: Simone Wieser Date: 30.06.2015 Specimens The specimens used for analysis
More informationDownloaded from journal.qums.ac.ir at 6: on Monday September 3rd 2018
The Journal of Qazvin Univ. of Med. Sci. No. 31, Summer 2004 - - * Assessment of mutual impact of different sodium citrate concentrations and minimum specimen volume on the result of routine coagulation
More informationThe study has been approved by Ethics Commission. Informed consent has been given by all participants.
Evaluation of new 9NC Coagulation Tubes Background: Venous blood with sodium citrate is the most commonly obtained examination sample for coagulation determinations. The additive functions as an anticoagulant
More informationUse of PSI on CS instruments
Johan Claes, Version 01, 1 st September 2016 User day hemostasis 2016 Use of PSI on CS instruments Restricted Siemens Healthcare GmbH, 2016 Hemostasis Lab Challenges Preanalytical problems in Haemostasis
More informationUnderstanding Quality Control for Infectious Disease Testing. Wayne Dimech ASLM Quality Control Workshop Abuja, Nigeria 9 th December 2018
Understanding Quality Control for Infectious Disease Testing Wayne Dimech ASLM Quality Control Workshop Abuja, Nigeria 9 th December 2018 Disclosure Attendance at ASLM part-sponsored by CDC No personal
More informationEvaluation of the Precision and Accuracy of the INRatio 2 Prothrombin Time (PT) Monitoring System
Evaluation of the Precision and Accuracy of the INRatio 2 Prothrombin Time (PT) Monitoring System Grace DeSantis, PhD Lisa Croner, PhD Michealle Havenhill, BA Shari Kipp, BSc (Honours) MBA Inverness Medical,
More informationThe analytical phase
The analytical phase Result interpretation Test request Result Sampling Black box: the lab ANALYTICAL PHASE The CASE Uncle Pete, 67 years old Marked abdominal pain 8 pm, ED Acute abdomen? Assessment (+
More informationWhat I will talk about
EQA of POCT methods: How to interpret results? Anne Stavelin Labquality Days, Helsinki 12 February 2016 www.noklus.no Norwegian quality improvement of primary care laboratories What I will talk about What
More informationDetermination of APTT factor sensitivity the misguiding guideline
International Journal of Laboratory Hematology ORIGINAL ARTICLE The Official journal of the International Society for Laboratory Hematology INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY Determination
More informationTwo Important Statistics
Two Important Statistics 70% 40% 0 Quality Control & YOU David Plaut Fall, 2012 davidplaut@yahoo.com 1 11 Why do physicians order laboratory tests? 2 2 Why do Physicians Order Laboratory Tests? 1. Patients
More informationA validation study of after reconstitution stability of diabetes: level 1 and diabetes level 2 controls
A validation study of after reconstitution stability of diabetes: level 1 and diabetes level 2 controls Shyamali Pal R B Diagnostic Private Limited, Lake Town, Kolkata, India INFO ABSTRACT Corresponding
More informationAlere INRatio 2 METHOD AND SAMPLE COLLECTION
Alere INRatio 2 METHOD AND SAMPLE COLLECTION 1. PURPOSE AND SCOPE The purpose of this document is to describe the procedure for performing an INR test using the Alere INRatio2 analyser. The INRatio2 meter
More informationMulticenter evaluation of the CoaguChek Prothrombin Time (PT) Test on the CoaguChek Pro II meter White paper
Multicenter evaluation of the CoaguChek Prothrombin Time (PT) Test on the CoaguChek Pro II meter White paper Contents Summary...3 Introduction...4 Intended use...4 Fields of application...4 Enhanced features
More informationHIV Viral Load Quality Assessment Program Summary for Panel HIVVL 2018Oct26
1 National Laboratory for HIV Reference Services National HIV and Retrovirology Laboratories National Microbiology Laboratory Public Health Agency of Canada HIV Viral Load Quality Assessment Program Summary
More information6 semanas de embarazo. Critical pt inr levels. Inicio / Embarazo / 6 semanas de embarazo
Inicio / Embarazo / 6 semanas de embarazo 6 semanas de embarazo Critical pt inr levels INR is the result of the patient PT/mean normal PT, exponentially equalized by the ISI. INR levels above 4.9 are considered
More informationQuality Control for Point-of-Care Testing
Quality Control for Point-of-Care Testing James H. Nichols, PhD, DABCC, FACB Professor of Pathology, Microbiology and Immunology Medical Director of Clinical Chemistry and Point-of-Care Testing Vanderbilt
More informationApplicable To NOTE: CAPILLARY PUNCTURE-DO NOT WIPE AWAY THE FIRST DROP OF BLOOD.
Subject PT-INR Whole Blood using CoaguChek XS Plus or Pro Test System Index Number Lab-1017 Section Laboratory Subsection Point of Care Testing Category Departmental Contact Rachel Blum Last Revised 9/26/2017
More informationPractical relevance of measurement uncertainty in inborn errors of metabolism. Prof Jim Bonham Clinical Director Sheffield Children s NHS FT
Practical relevance of measurement uncertainty in inborn errors of metabolism Prof Jim Bonham Clinical Director Sheffield Children s NHS FT Outline Is it important for inborn errors? What is measurement
More informationToxicology Blood Lead Comprehensive Testing
Clinical Laboratory s of Practice Blood Lead Comprehensive Testing The following specialty sustaining standards of practices shall be incorporated into the laboratory s quality management system, where
More informationCoaguChek XS Plus System Whole Blood Protime/INR
1 CoaguChek XS Plus System Whole Blood Protime/INR A. PURPOSE The CoaguChek XS System is intended for use by professional healthcare providers for quantitative protime testing (PT) and calculated INR for
More informationRoche CoaguChek XS Plus Error Codes For Firmware Version onwards
Roche CoaguChek XS Plus Error Codes For Firmware Version 03.01.00 onwards Description of Error The instrument will not turn on -The instrument has 'frozen' or not receiving power -Remove the power to the
More informationJournal of Assisted Reproduction and Genetics Plenum Publishing Corporation All Rights Reserved.
Journal of Assisted Reproduction and Genetics Plenum Publishing Corporation 2003. All Rights Reserved. Volume 20(1) January 2003 p 38 45 Can Westgard Quality Control Rules Determine the Suitability of
More informationStability of prothrombin time and activated partial thromboplastin time tests under different storage conditions
Clinica Chimica Acta 300 (2000) 13 21 www.elsevier.com/ locate/ clinchim Stability of prothrombin time and activated partial thromboplastin time tests under different storage conditions L.V. Rao *, A.O.
More informationPROFICIENCY TESTING POLICY
Supersedes Prepared by: APPROVALS in this section Approved by: Date: Laboratory Director RECORD OF REVIEWS Date Signature Title Procedural Changes/Review VERSION HISTORY Revision # 0 Section #/Changes
More informationToxicology Blood Lead Comprehensive Testing
Clinical Laboratory s of Practice Blood Lead Comprehensive Testing The following specialty sustaining standards of practices shall be incorporated into the laboratory s quality management system, where
More informationThis is a CLIA-waived system. Policies and Procedures Manual
This is a CLIA-waived system. Policies and Procedures Manual Approval date Approved by Reviewed/Revised: Date By whom Title Roche Diagnostics 9115 Hague Road Indianapolis, IN 46256 www.poc.roche.com COAGUCHEK
More informationDIAGNOSTICS ASSESSMENT PROGRAMME
THEME: EFFECTIVENESS OF INRatio2 PT/INR MONITOR Comment Name and number organisation 1. Consultee 10: Alere Section number Section1 Comment We do not agree that the INRatio2 PT/ INR monitor is only recommended
More informationPolymer Technology Systems, Inc. CardioChek PA Comparison Study
Polymer Technology Systems, Inc. CardioChek PA Comparison Study Evaluation Protocol: Accuracy Precision Clinical Correlation PTS Panels Lipid Panel Test Strips For Use in Comparisons to a Reference Laboratory
More informationI know my value CoaguChek XS Pro system
I know my value CoaguChek XS Pro system The smart way to manage your anticoagulation clinic CoaguChek XS Pro system A barcode scanner can make a difference There has been an extraordinary increase in the
More informationInsights on the Quality of Coagulation Testing
Insights on the Quality of Coagulation Testing Piet Meijer ECAT Foundation The Netherlands No conflicts of interest HAEMOSTATIC BALANCE BLEEDING HAEMOSTATIC BALANCE THROMBOSIS HAEMOSTATIC BALANCE Thrombosis
More informationToxicology Blood Lead Comprehensive Testing
Blood Lead Comprehensive Testing The following specialty sustaining standards of practices shall be incorporated into the laboratory s quality management system, where applicable to the scope of services
More informationHematology & Coagulation Practicum Objectives CLS - 647
Hematology & Coagulation Practicum Objectives CLS - 647 The following objectives are to be completed by the student for successful completion of this clinical rotation. The objectives within the psychomotor
More informationVitamin K antagonist (VKA) therapy is routinely
International Normalized Ratio Versus Plasma Levels of Coagulation Factors in Patients on Vitamin K Antagonist Therapy Gene Gulati, PhD; Megan Hevelow, MS; Melissa George, DO; Eric Behling, MD; Jamie Siegel,
More informationQuality Controls in Allergy Diagnosis
Quality Controls in Allergy Diagnosis Alistair Crockard Royal Hospitals Belfast Northern Ireland Quality Controls in Allergy What do we want? Diagnosis What can be controlled? What can be achieved? What
More informationDiagnostics Assessment Programme. Final scope
Diagnostics Assessment Programme Self-monitoring coagulometers (CoaguChek XS system, INRatio2 PT/INR monitor and ProTime Microcoagulation system), for selftesting or self-managing coagulation status in
More informationThe good, the bad, the ugly A month in the life of a Point Of Care Coordinator
The good, the bad, the ugly A month in the life of a Point Of Care Coordinator Stefanie Van Heule Ghent University Hospital 23/10/2014 Ghent University Hospital ± 3000 patients / day ± 62 000 total admissions
More informationAlere Triage System. Knowing now matters when rapid treatment decisions can be made at the point-of-care.
System Knowing now matters when rapid treatment decisions can be made at the point-of-care. The Alere Triage System The MeterPro is utilized in thousands of healthcare facilities worldwide. A comprehensive
More informationQuality control in the hematology laboratory for the sake of the patient. Dr Marion Münster Manager Medical & Scientific Affairs Sysmex South Africa
Quality control in the hematology laboratory for the sake of the patient Dr Marion Münster Manager Medical & Scientific Affairs Sysmex South Africa The FBC. Most frequently requested lab test Usually delegated
More informationBassett Healthcare Clinical Laboratory
Therapeutic Drug Level Collection Guidelines Anti-epileptic drugs (carbamazepine, phenobarbital, phenytoin, primidone, valproic acid) Consider collecting after steady state conditions are reached, i.e.
More informationWe are writing to inform you about an issue concerning your CoaguChek system and test strips. Please read this information carefully.
Consumer Letter (CoaguChek XS PT Test PST, CoaguChek XS PT Test, CoaguChek PT Test) Urgent Field Safety Notice Location, Date We are writing to inform you about an issue concerning
More informationfritsmafactor.com Coag QA: Why are we Different? Prothrombin Time 1980: PT Ratio Based on MRI PTR = PTpatient PTMRI
Coag QA: Why are we Different? 4-28-15 Objectives Coagulation Laboratory Quality Assurance Why Are We Different? Compute and report the PT/INR Computing the ISI Local INR validation Local ISI calibration
More informationLeadCare BLOOD LEAD ANALYZER. Quick Reference Guide
LeadCare II BLOOD LEAD ANALYZER Quick Reference Guide Precautions Precautions Caution The LeadCare II Blood Lead Analyzer is a CLIA-waived device. Facilities that perform tests with the LeadCare II System
More informationThe Laboratories Role in Global Health
The Laboratories Role in Global Health Larry Westerman, Ph.D. International Laboratory Branch Division of Global HIV/AIDS Centers for Disease Control and Prevention Center for Global Health International
More informationIndividual Quality Control Plans (IQCP) Risk Assessment
Individual Quality Control Plans (IQCP) Risk Assessment James H. Nichols, PhD, DABCC, FACB Professor of Clinical Pathology, Microbiology and Immunology Medical Director of Clinical Chemistry and Point-of-Care
More informationWhat information on measurement uncertainty should be communicated to clinicians, and how? Mario Plebani
What information on measurement uncertainty should be communicated to clinicians, and how? Mario Plebani OUTLINE OF TALK Uncertainty in medicine and shared decision making Measurement uncertainty in laboratory
More informationWorkshop on Proficiency Testing for Medical Laboratories. Daniel W. Tholen, M.S. March 13, 2013
Workshop on Proficiency Testing for Medical Laboratories Daniel W. Tholen, M.S. March 13, 2013 Workshop Schedule It s a Workshop! not a lecture Discussion expected My background in PT for medical laboratories
More informationThe Quidel Triage System
The Quidel Triage System Automated. Calibrated. Connected. Professional diagnostics at the point-of-care BR1026500EN00.qxp_Layout 1 8/28/18 2:28 PM Page 4 The Quidel Triage System Fast quantitative results
More informationGuide to Fulfillment of Measurement Uncertainty
DIAGNOSTIC ACCREDITATION PROGRAM College of Physicians and Surgeons of British Columbia 300 669 Howe Street Telephone: 604-733-7758 ext. 2635 Vancouver BC V6C 0B4 Toll Free: 1-800-461-3008 (in BC) www.cpsbc.ca
More informationExendin-4 (Exenatide) ELISA Kit
Exendin-4 (Exenatide) ELISA Kit Catalog: DEIABL227 For the quantitative determination of Exendin-4 in serum or plasma using competitive ELISA method For Research Use Only. Protocol Provided for Informational
More informationQUANTIFYING THE EFFECT OF SETTING QUALITY CONTROL STANDARD DEVIATIONS GREATER THAN ACTUAL STANDARD DEVIATIONS ON WESTGARD RULES
AACC24 QUANTIFYING THE EFFECT OF SETTING QUALITY CONTROL STANDARD DEVIATIONS GREATER THAN ACTUAL STANDARD DEVIATIONS ON WESTGARD RULES Graham Jones Department of Chemical Pathology, St Vincent s Hospital,
More informationThe use of QCMD proficiency testing panels in clinical virology.
The use of QCMD proficiency testing panels in clinical virology. Prof.dr. Bert Niesters Department of Medical Microbiology Division of Clinical Virology UMC Groningen Disease Disease Management Viral Load
More informationGenerate Knowledge Pre-Analytical Variables in the Coagulation Lab: Why Does It Matter?
Generate Knowledge Pre-Analytical Variables in the Coagulation Lab: Why Does It Matter? Paul Riley, PhD, MBA Pre-Analytical Variables: Objectives 1. Define Pre-Analytical variables 2. Explain how blood
More informationAccuSet HBV Worldwide Performance Panel
PACKAGE INSERT 0805-033 INTENDED USE The is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot HBV test methods. Characterized samples
More informationBasic knowledge of POCT instuments. The Tide Resort Bangsan Beach 18 June 2009
Basic knowledge of POCT instuments The Tide Resort Bangsan Beach 18 June 2009 1 POCT instruments concepts Point of care testing Diagnostic medical devices used at or near the site of patient care Bed site,
More informationPoint of Care (POC) Glucose Testing Revised on: December, 2018 Reference: Policy LAB 23-A; Point of Care Nova Stat Strip Glucose Meter
Point of Care (POC) Glucose Testing Revised on: December, 2018 Reference: Policy LAB 23-A; Point of Care Nova Stat Strip Glucose Meter The Nova Stat Strip Blood Glucose meter is UHB s approved Glucometer
More informationEffects of preanalytical frozen storage time and temperature on screening coagulation tests and factors VIII and IX activity
www.nature.com/scientificreports Received: 8 February 2017 Accepted: 30 August 2017 Published: xx xx xxxx OPEN Effects of preanalytical frozen storage time and temperature on screening coagulation tests
More informationCardiac Assessment Controls A critical element of reliable cardiac testing
Cardiac Assessment Controls Cardiac Assessment Controls A critical element of reliable cardiac testing Choose the products best suited for your cardiac assessment needs Each year, 17.7 million people on
More informationEDUCATIONAL COMMENTARY ORAL ANTICOAGULANT THERAPEUTIC MONITORING AND POINT-OF-CARE TESTING
POINT-OF-CARE TESTING Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Continuing Education on
More informationIndividual Lab Report Ci-Trol Nov,2016. Abnormal Fibrinogen (mg/dl) Abnormal Fbg Control - Lot# LFC Your Lab
Individual Lab Report Ci-Trol Nov,2016 ST VINCENT MEDICAL CENTER LABORATORY(LAB# 7300 ) 2131 WEST THIRD STREET LOS ANGELES CA USA 90057 Abnormal Fibrinogen (mg/dl) Abnormal Fbg Control - Lot# LFC SYSMEX
More informationGeneral approach to the investigation of haemostasis. Jan Gert Nel Dept. of Haematology University of Pretoria 2013
General approach to the investigation of haemostasis Jan Gert Nel Dept. of Haematology University of Pretoria 2013 Clinical reasons to investigate haemostasis Investigating a clinically suspected bleeding
More informationSpecimen Management PHRU LAB
Specimen Management PHRU LAB Amanda Mohlala, MT(HPCSA) Perinatal HIV Research Unit University of the Witwatersrand Chris Hani Baragwanath Hospital Johannesburg, South Africa MTN Regional Meeting 2010 PHRU
More informationPoint of Care testing refers to all laboratory testing that is done outside of the walls of the clinical laboratory in the proximity of the patient.
1 2 Point of Care testing refers to all laboratory testing that is done outside of the walls of the clinical laboratory in the proximity of the patient. All such tests are considered lab tests and are
More informationSummary of Significant Changes at this Revision
COPY Summary of Significant Changes at this Revision CR5890 Removal of Ketone guidelines - refer to Specialist Diabetes nurse (adult wards); Children's ward has their own protocol Remove all references
More informationWeek 17 and 21 Comparing two assays and Measurement of Uncertainty Explain tools used to compare the performance of two assays, including
Week 17 and 21 Comparing two assays and Measurement of Uncertainty 2.4.1.4. Explain tools used to compare the performance of two assays, including 2.4.1.4.1. Linear regression 2.4.1.4.2. Bland-Altman plots
More informationAdditional cost-effectiveness analysis scenarios prepared for the Diagnostic Advisory Committee. Produced by the Aberdeen HTA group
The clinical and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving
More informationRoutine, Every 2 hours, Starting today, If temperature greater than 38.5 C initiate Evaluation for Possible Sepsis Physician Order #829
Height Weight Allergies General Vital Signs [X] Frequent vital signs Indication: Q15 minutes x (# of occurrences): 4 Q30 minutes x (# of occurrences): 4 Q1 hour x (# of occurrences): Q2 hours x (# of occurrences):
More information3. System Accuracy Evaluation LUX Hgb test 1. Samples
3. System Accuracy Evaluation LUX Hgb test 1. Samples - Type of sample: Capillary Blood System accuracy evaluation was performed with 200 fresh capillary blood samples, each with sufficient volume to be
More informationThe Virtues and Pitfalls of Implementing a New Test
The Virtues and Pitfalls of Implementing a New Test James H. Nichols, Ph.D., DABCC, FACB Professor of Clinical Pathology, Microbiology and Immunology Associate Medical Director for Clinical Operations
More informationRecommended Additional EUA QC checks for Zika MAC-ELISA. Wendi Kuhnert, PhD Co-Lead, Zika Laboratory Task Force
Recommended Additional EUA QC checks for Zika MAC-ELISA Wendi Kuhnert, PhD Co-Lead, Zika Laboratory Task Force Current Plans 3 Phase approach to standardize the Zika MAC-ELISA Phase 1: Distribution of
More informationPROCEDURE NO. POC LBH. Printed copies are for reference only. Please refer to the electronic copy for the latest version.
Department Of Pathology POC.514.06- Blood Glucose Monitoring Accu-Chek Inform II Procedure-LBH Version# 6 Department PROCEDURE NO. PAGE NO. Point-of-Care Testing POC.514.05 LBH 1 OF 7 Printed copies are
More informationAccuSet Autoimmune Performance Panel
PACKAGE INSERT 0840-0001 INTENDED USE The 0840-0001 is intended for use by diagnostic manufacturers, researchers, and clinical laboratories to develop, evaluate, or troubleshoot autoimmune related test
More informationCommutability studies undertaken by the LNE : the case of lipid and lipoprotein testing. Vincent Delatour, PhD
Commutability studies undertaken by the LNE : the case of lipid and lipoprotein testing Vincent Delatour, PhD 1 Traceability in laboratory medicine : regulatory drivers Reform of medical biology in France
More informationURGENT FIELD SAFETY NOTICE IMMEDIATE ACTION REQUIRED
Ref No: Date: 17.09.2018 Type of Action: PFSN18 Deviations of high (>4.5) CoaguChek INR values due to masterlot calibration issue SBN-CPS-2018-014-v2.0 Field Safety Corrective Action (FSCA) Product Affected:
More informationLaboratory Procedure Manual
Laboratory Procedure Manual Analyte: Matrix: Method: as performed by: Fasting Glucose Plasma Hexokinase-mediated reaction University of Minnesota Medical Center, Fairview Collaborative Studies Clinical
More informationTitle: Abbott Optium Xceed Glucose Meter Effective date: 16/05/2011. Summary of Significant Changes at this Revision. SOP updated.
COPY Summary of Significant Changes at this Revision SOP updated Purpose and Scope Items Required 1. The Abbott Optium Xceed meter is a battery-powered device designed for the measurement of blood glucose
More informationTRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006
TRANSFUSION GUIDELINES FOR CARDIOTHORACIC UNIT 2006 CTU blood product transfusion guidelines 2006 1 Summary of guidelines RED CELLS (10-15ml/kg) This applies to ward patients / icu patients who are stable.
More informationGUIDELINE: ASSESSMENT OF BRUISING & BLEEDING IN CHILDREN. All children in whom there is concern regarding bruising / bleeding
GUIDELINE: ASSESSMENT OF BRUISING & BLEEDING IN CHILDREN Reference: Bruising / Bleeding / NAI Version No: 1 Applicable to All children in whom there is concern regarding bruising / bleeding Classification
More informationURGENT FIELD SAFETY NOTICE IMMEDIATE ACTION REQUIRED
Ref No: Date: 22.08.2018 Type of Action: PFSN18 Deviations of high (>4.5) CoaguChek INR values due to calibration with WHO reference standard rtf/16 SBN-CPS-2018-014 Field Safety Corrective Action (FSCA)
More informationIt s a Gas! Issues in the Blood Gas Laboratory. D. Robert Dufour, MD, FCAP Consultant Pathologist VA Medical Center, Washington DC
It s a Gas! Issues in the Blood Gas Laboratory D. Robert Dufour, MD, FCAP Consultant Pathologist VA Medical Center, Washington DC Learning Objectives After participating in this session, you will be able
More informationIt s Just a Waived Glucose, Isn t It?
It s Just a Waived Glucose, Isn t It? What Is the Next Step? Becky Damiani, MT (ASCP), Senior Inspection Specialist Laboratory Accreditation Program Objectives Understand the CLIA requirements surrounding
More informationCustomer Bulletin. Questions/Comments? Please call Customer Service at (Direct) or (Toll-free inside USA).
Customer Bulletin Assignment of Ranges for PTS Panels Multi-Chemistry Controls (Cat. No./REF 721) and PTS Panels Controls (Cat. No./REF 722) Background: PTS Panels Multi-Chemistry Controls and Controls
More informationPresented by Marcelo Cardona, MT(ASCP) Johns Hopkins University
Presented by Marcelo Cardona, MT(ASCP) Johns Hopkins University Alert or critical values represent those assay results that require prompt, rapid clinical attention to avert significant study-participant
More informationIntroduction to coagulation and laboratory tests
Introduction to coagulation and laboratory tests Marc Jacquemin Special Haemostasis Laboratory Center for Molecular and Vascular Biology University of Leuven Coagulation in a blood vessel: fibrin stabilises
More information